Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,676–3,700 of 7,816 matching trials · page 148 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease NCT05792163 SNP318 (A); Placebo (B) Runs in: Australia · 1 site |
PHASE1 other |
COMPLETED | 76 | SciNeuro INDUSTRY |
2023-12-15 |
|
Remote Balance Training for Individuals With Dementia NCT05558215 Otago Exercise Program Runs in: United States · 1 site |
NA other |
UNKNOWN | 18 | Marymount University OTHER |
2023-12-14 |
|
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) NCT06170268 Routine Care Documentation Runs in: United States · 1 site |
NA other |
RECRUITING | 20,000 | Alzheimer's Disease and Related Disorders Association, Inc OTHER |
2023-12-14 |
|
PatientSpot Formerly Known as ArthritisPower NCT03840928 Runs in: United States · 1 site |
NA other |
UNKNOWN | 40,000 | Global Healthy Living Foundation OTHER |
2023-12-13 |
|
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia NCT04405596 Ambroxol Hydrochloride; Placebo Runs in: Canada · 1 site |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 15 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2023-12-13 |
|
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study NCT05728801 Ageing Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 400 | Chinese University of Hong Kong OTHER |
2023-12-12 |
|
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) NCT05665088 BXCL501; Matching Placebo Runs in: United States · 7 sites |
PHASE3 other |
TERMINATED | 13 | BioXcel Therapeutics Inc INDUSTRY |
2023-12-11 |
|
GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia. NCT06163716 Multidomain intervention (MD-Int) group Runs in: Spain · 1 site |
NA other |
COMPLETED | 125 | Fundacion CITA-alzheimer OTHER |
2023-12-11 |
|
Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE) NCT04413877 |
NA other |
WITHDRAWN | 0 | University of Liege OTHER |
2023-12-08 |
|
Effects of an Algorithmically Enhanced Personalized Music-based Intervention in Patients With Dementia NCT06163378 Rubato Life App Runs in: United States · 1 site |
NA other |
UNKNOWN | 100 | Rubato Life OTHER |
2023-12-08 |
|
PET Imaging in MCI Following ADT for PCa NCT02061345 Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 11 | Imperial College London OTHER |
2023-12-07 |
|
Early Diagnosis of Patients With Mild Cognitive Impairment Through the Parameterization of Functional Tests. NCT03851198 Standard Care or Usual Clinical Practice Runs in: Spain · 1 site |
NA other |
WITHDRAWN | 0 | University of Malaga OTHER |
2023-12-07 |
|
Music Based Caregiving in Patients With Pain and Dementia NCT04229446 Music based caregiving Runs in: Norway · 2 sites |
NA other |
COMPLETED | 276 | Oslo University Hospital OTHER |
2023-12-07 |
|
Economic Evaluation of the MEWE Intervention NCT05598697 Life Skills Building (LSB) curriculum for males; Life Skills Buildi... Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 1,536 | London School of Economics and Political Science OTHER |
2023-12-07 |
|
Study of BHV-4157 in Alzheimer's Disease NCT03605667 troriluzole; Placebo oral capsule Runs in: United States · 44 sites |
PHASE2 other |
COMPLETED | 350 | Biohaven Pharmaceuticals, Inc. INDUSTRY |
2023-12-06 |
|
Digital Evaluations and Technologies Enabling Clinical Translation for AD NCT05385913 Multivitamin-no intervention Runs in: United States · 1 site |
NA other |
UNKNOWN | 200 | Oregon Health and Science University OTHER |
2023-12-06 |
|
Cross-cultural Adaptation of the Greek Version of Disability Assessment for Dementia NCT05850715 Disability Assessment for Dementia (DAD) Runs in: Greece · 1 site |
NA other |
COMPLETED | 30 | University of Thessaly OTHER |
2023-12-06 |
|
HEalthy Aging Team Supported Home-care Services (HEAT-YASAM) NCT05993572 Comprehensive Geriatric Assessment Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 2,000 | Gulhane Training and Research Hospital OTHER_GOV |
2023-12-06 |
|
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease. NCT06158789 MR guided low intensity focused ultrasound Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 6 | Kyung Won Chang OTHER |
2023-12-06 |
|
Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy NCT03335696 Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 800 | University of Oxford OTHER |
2023-12-05 |
|
DHS MIND Metabolomics NCT03975309 Runs in: United States · 1 site |
NA other |
COMPLETED | 417 | Wake Forest University Health Sciences OTHER |
2023-12-05 |
|
Deep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose Optimization NCT04856072 Deep Brain Stimulation Runs in: Canada · 1 site |
NA other |
COMPLETED | 11 | University Health Network, Toronto OTHER |
2023-12-05 |
|
Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's Disease NCT05784298 low-intensity rTMS Runs in: Mexico · 1 site |
NA other |
COMPLETED | 27 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran OTHER |
2023-12-05 |
|
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort. NCT06156917 diagnostic accuracy Runs in: Italy · 1 site |
NA other |
COMPLETED | 100 | IRCCS San Raffaele OTHER |
2023-12-05 |
|
Sleep Well for Healthy Brain NCT04583033 Cognitive Behavioral Therapy (CBT) Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | University of Miami OTHER |
2023-12-01 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial